Background: Anticoagulant assumption is a concern in neurosurgical patient that implies a delicate balance between the risk of thromboembolism versus the risk of peri- and postoperative hemorrhage.
How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH)
Alessandro Prior # 1, Pietro Fiaschi # 2 3, Corrado Iaccarino 4, Roberto Stefini 5, Denise Battaglini 6 7, Alberto Balestrino 1, Pasquale Anania 1, Enrico Prior 8, Gianluigi Zona 1 9Affiliations expand
- PMID: 33658003
- PMCID: PMC7927258
- DOI: 10.1186/s12883-021-02126-7
Free PMC article – BMC Neurol – 2021 Mar 3;21(1):98. doi: 10.1186/s12883-021-02126-7.
Methods: We performed a survey among 129 different neurosurgical departments in Italy to evaluate practice patterns regarding the management of neurosurgical patients taking anticoagulant drugs. Furthermore, we reviewed the available literature, with the aim of providing a comprehensive but practical summary of current recommendations.
Results: Our survey revealed that there is a lack of knowledge, mostly regarding the indication and the strategies of anticoagulant reversal in neurosurgical clinical practice. This may be due a lack of national and international guidelines for the care of anticoagulated neurosurgical patients, along with the fact that coagulation and hemostasis are not simple topics for a neurosurgeon.
Conclusions: To overcome this issue, establishment of hospital-wide policy concerning management of anticoagulated patients and developed in an interdisciplinary manner are strongly recommended.
Keywords: Anticoagulant; Neurosurgery; Reversal therapy; Spontaneous intracerebral hemorrhage; Traumatic brain injury.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927258/
